Surgery Partners Stock Analysis

Surgery Stock Analysis Notes

About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.16. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surgery Partners has Price/Earnings To Growth (PEG) ratio of 1.66. The entity recorded a loss per share of 1.36. The firm had not issued any dividends in recent years. Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee. Surgery Partners operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 8300 people. To find out more about Surgery Partners contact the company at 615 234 5900 or learn more at https://www.surgerypartners.com.

Surgery Partners Investment Alerts

Surgery Largest EPS Surprises

View All Earnings Estimates

Surgery Partners Environmental, Social, and Governance (ESG) Scores

Surgery Stock Institutional Investors

Note, although Surgery Partners' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Surgery Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.05 B.

Surgery Profitablity

The company has Profit Margin (PM) of (0.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15.

Management Efficiency

Surgery Partners has return on total asset (ROA) of 0.0374 % which means that it generated a profit of $0.0374 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0276 %, meaning that it created $0.0276 on every $100 dollars invested by stockholders. Surgery Partners' management efficiency ratios could be used to measure how well Surgery Partners manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to rise to 0.06 in 2026, whereas Return On Tangible Assets are likely to drop (0.03) in 2026. At this time, Surgery Partners' Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to rise to about 956.3 M in 2026, whereas Total Assets are likely to drop slightly above 5.3 B in 2026.

Technical Drivers

As of the 4th of March, Surgery Partners has the Risk Adjusted Performance of (0.06), variance of 7.73, and Coefficient Of Variation of (1,097). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Surgery Partners, as well as the relationship between them.

Surgery Partners Price Movement Analysis

Surgery Partners Insider Trading Activities

Surgery Partners Outstanding Bonds

Surgery Partners Predictive Daily Indicators

Surgery Partners Corporate Filings

Surgery Partners Forecast Models

Surgery Partners' time-series forecasting models are one of many Surgery Partners' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Surgery Partners' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Surgery Partners Bond Ratings

Surgery Partners financial ratings play a critical role in determining how much Surgery Partners have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Surgery Partners' borrowing costs.

Surgery Partners Debt to Cash Allocation

Surgery Partners currently holds 379.2 M in liabilities with Debt to Equity (D/E) ratio of 1.44, which is about average as compared to similar companies. Surgery Partners has a current ratio of 1.48, which is within standard range for the sector. Note, when we think about Surgery Partners' use of debt, we should always consider it together with its cash and equity.

Surgery Partners Common Stock Shares Outstanding Over Time

Surgery Partners Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Surgery Partners uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Surgery Partners Debt Ratio

4.44

It appears most of the Surgery Partners' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Surgery Partners' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Surgery Partners, which in turn will lower the firm's financial flexibility.

Surgery Partners Corporate Bonds Issued

Surgery Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Surgery Partners prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Surgery shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Surgery Partners. By using and applying Surgery Stock analysis, traders can create a robust methodology for identifying Surgery entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Surgery analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Surgery analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Surgery Partners stock analysis indicators help investors evaluate how Surgery Partners stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Surgery Partners shares will generate the highest return on investment. By understating and applying Surgery Partners stock analysis, traders can identify Surgery Partners position entry and exit signals to maximize returns.

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.